{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:25:55Z","timestamp":1790195155347,"version":"4.1.0"},"reference-count":40,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.m2025.0227","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T11:05:56Z","timestamp":1779188756000},"source":"Crossref","is-referenced-by-count":2,"title":["Transplacental infection: Frequency, testing, and treatment"],"prefix":"10.3238","author":[{"given":"Christoph","family":"H\u00e4rtel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl Oliver","family":"Kagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothee","family":"Viemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael O.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Enders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"10.3238\/arztebl.m2025.0227_ref1","unstructured":"WHO Global Maternal Sepsis Study (GLOSS) Research Group: Frequency and management of maternal infection in health facilities in 52 countries (GLOSS): A 1-week inception cohort study. Lancet Glob Health 2020; 8: e661\u2013e71."},{"key":"10.3238\/arztebl.m2025.0227_ref2","doi-asserted-by":"crossref","unstructured":"Fouks Y, Many A, Shulman Y, Bak S, Shinar S: The contribution of an infectious workup in understanding stillbirth. Am J Perinatol 2021; 38: 377\u201382","DOI":"10.1055\/s-0039-1697668"},{"key":"10.3238\/arztebl.m2025.0227_ref3","doi-asserted-by":"crossref","unstructured":"Boyle B, Addor MC, Arriol L, et al.: Estimating global burden of disease due to congenital anomaly: An analysis of European data. Arch Dis Child Fetal Neonatal Ed 2018; 103: F22\u2013F8","DOI":"10.1136\/archdischild-2016-311845"},{"key":"10.3238\/arztebl.m2025.0227_ref4","doi-asserted-by":"crossref","unstructured":"Leruez-Ville M, Chatzakis C, Lilleri D, et al.: Consensus recommendation for prenatal, neonatal and postnatal management of congenital cytomegalovirus infection from the European congenital infection initiative (ECCI). Lancet Reg Health Eur 2024; 40: 100892","DOI":"10.1016\/j.lanepe.2024.100892"},{"key":"10.3238\/arztebl.m2025.0227_ref5","doi-asserted-by":"crossref","unstructured":"Garweg JG, Kieffer F, Mandelbrot L, Peyron F, Wallon M: Long-term outcomes in children with congenital toxoplasmosis\u2014a systematic review. Pathogens 2022; 11: 1187","DOI":"10.3390\/pathogens11101187"},{"key":"10.3238\/arztebl.m2025.0227_ref6","doi-asserted-by":"crossref","unstructured":"Abu-Raya B, Michalski C, Sadarangani M, Lavoie PM: Maternal immunological adaptation during normal pregnancy. Front Immunol 2020; 11: 575197","DOI":"10.3389\/fimmu.2020.575197"},{"key":"10.3238\/arztebl.m2025.0227_ref7","doi-asserted-by":"crossref","unstructured":"Rowe JH, Ertelt JM, Aguilera MN, Farrar MA, Way SS: Foxp3(+) regulatory T cell expansion required for sustaining pregnancy compromises host defense against prenatal bacterial pathogens. Cell Host Microbe 2011; 10: 54\u201364","DOI":"10.1016\/j.chom.2011.06.005"},{"key":"10.3238\/arztebl.m2025.0227_ref8","doi-asserted-by":"crossref","unstructured":"Stafford IA, Workowski KA, Bachmann LH: Syphilis complicating pregnancy and congenital syphilis. N Engl J Med 2024; 390: 242\u201353","DOI":"10.1056\/NEJMra2202762"},{"key":"10.3238\/arztebl.m2025.0227_ref9","doi-asserted-by":"crossref","unstructured":"Kagan KO, Hoopmann M, Geipel A, Sonek J, Enders M: Prenatal parvovirus B19 infection. Arch Gynecol Obstet 2024; 310: 2363\u201371","DOI":"10.1007\/s00404-024-07644-6"},{"key":"10.3238\/arztebl.m2025.0227_ref10","doi-asserted-by":"crossref","unstructured":"Pereira L: Congenital viral infection: Traversing the uterine-placental interface. Annu Rev Virol 2018; 5: 273\u201399","DOI":"10.1146\/annurev-virology-092917-043236"},{"key":"10.3238\/arztebl.m2025.0227_ref11","unstructured":"Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). S2k-Leitlinie 093\u2013003: Pr\u00e4vention, Diagnostik und Therapie der CMV-Infektion bei Schwangeren und der konnatalen CMV-Infektion bei Neugeborenen und Kindern. Version 1.0. 2025. https:\/\/register.awmf.org\/assets\/guidelines\/093-003l_S2k_Praevention-Diagnostik-Therapie-CMV-Infektion-Schwangere-konnatalen-CMV-Infektion-Neugeborene-Kinder_2025-04.pdf (last accessed on 19 October 2025)."},{"key":"10.3238\/arztebl.m2025.0227_ref12","doi-asserted-by":"crossref","unstructured":"Keymeulen A, De Leenheer E, Casaer A, et al.: Neurodevelopmental outcome in children with congenital cytomegalovirus infection: A prospective multicenter cohort study. Early Hum Dev 2023; 182: 105777","DOI":"10.1016\/j.earlhumdev.2023.105777"},{"key":"10.3238\/arztebl.m2025.0227_ref13","unstructured":"Gemeinsamer Bundesausschuss (G-BA). Mutterschafts-Richtlinien (Mu-RL). G-BA; 2023. www.g-ba.de\/downloads\/62-492-3335\/Mu-RL_2023-09-28_iK-2023-12-19.pdf (last accessed on 18 October 2025)."},{"key":"10.3238\/arztebl.m2025.0227_ref14","doi-asserted-by":"crossref","unstructured":"Shahar-Nissan K, Pardo J, Peled O, et al.: Valaciclovir to prevent vertical transmission of cytomegalovirus after maternal primary infection during pregnancy: A randomised, double-blind, placebo-controlled trial. Lancet 2020; 396: 779\u201385","DOI":"10.1016\/S0140-6736(20)31868-7"},{"key":"10.3238\/arztebl.m2025.0227_ref15","doi-asserted-by":"crossref","unstructured":"Chatzakis C, Shahar-Nissan K, Faure-Bardon V, et al.: The effect of valacyclovir on secondary prevention of congenital cytomegalovirus infection, following primary maternal infection acquired periconceptionally or in the first trimester of pregnancy. An individual patient data meta-analysis. Am J Obstet Gynecol 2024; 230: 109\u201317","DOI":"10.1016\/j.ajog.2023.07.022"},{"key":"10.3238\/arztebl.m2025.0227_ref16","doi-asserted-by":"crossref","unstructured":"Bourgon N, Lopez R, Fourgeaud J, et al.: In utero treatment of congenital cytomegalovirus infection with valganciclovir: An observational study on safety and effectiveness. J Antibiot Chemoth 2024; 79: 2500\u201308","DOI":"10.1093\/jac\/dkae247"},{"key":"10.3238\/arztebl.m2025.0227_ref17","doi-asserted-by":"crossref","unstructured":"Kimberlin DW, Jester PM, S\u00e1nchez PJ, et al.: Valganciclovir for symptomatic congenital cytomegalovirus disease. N Engl J Med 2015; 372: 933\u201343","DOI":"10.1056\/NEJMoa1404599"},{"key":"10.3238\/arztebl.m2025.0227_ref18","doi-asserted-by":"crossref","unstructured":"Kimberlin DW, Aban I, Peri K, et al.: Oral valganciclovir initiated beyond 1 month of age as treatment of sensorineural hearing loss caused by congenital cytomegalovirus infection: A randomized clinical trial. J Pediatr 2024; 268: 113934","DOI":"10.1016\/j.jpeds.2024.113934"},{"key":"10.3238\/arztebl.m2025.0227_ref19","doi-asserted-by":"crossref","unstructured":"Chung PK, Schornagel FAJ, Soede W, et al.: Valganciclovir in infants with hearing loss and clinically inapparent congenital cytomegalovirus infection: A nonrandomized controlled trial. J Pediatr 2024; 268: 113945","DOI":"10.1016\/j.jpeds.2024.113945"},{"key":"10.3238\/arztebl.m2025.0227_ref20","unstructured":"Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF): S2k-Leitlinie 093\u2013001: Labordiagnostik schwangerschaftsrelevanter Virusinfektionen. Version 1.0. 2022. https:\/\/register.awmf.org\/assets\/guidelines\/093-001l_S2k_Labordiagnostik-schwangerschaftsrelevanter-Virusinfektionen_2022-02.pdf (last accessed on 12 February 2026)."},{"key":"10.3238\/arztebl.m2025.0227_ref21","doi-asserted-by":"crossref","unstructured":"R\u00f6hrer C, G\u00e4rtner B, Sauerbrei A, et al.: Seroprevalence of parvovirus B19 in the German population. Epidemiol Infect 2008; 136: 1564\u201375","DOI":"10.1017\/S0950268807009958"},{"key":"10.3238\/arztebl.m2025.0227_ref22","doi-asserted-by":"crossref","unstructured":"Enders M, Weidner A, Zoellner I, Searle K, Enders G: Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: Prospective evaluation of 1018 cases. Prenat Diagn 2004; 24: 513\u20138","DOI":"10.1002\/pd.940"},{"key":"10.3238\/arztebl.m2025.0227_ref23","doi-asserted-by":"crossref","unstructured":"Bascietto F, Liberati M, Murgano D, et al.: Outcome of fetuses with congenital parvovirus B19 infection: Systematic review and meta-analysis. Ultrasound Obstet Gynecol 2018; 52: 569\u201376","DOI":"10.1002\/uog.19092"},{"key":"10.3238\/arztebl.m2025.0227_ref24","doi-asserted-by":"crossref","unstructured":"Lindenburg IT, van Klink JM, Smits-Wintjens VE, van Kamp IL, Oepkes D, Lopriore E: Long-term neurodevelopmental and cardiovascular outcome after intrauterine transfusions for fetal anaemia: A review. Prenat Diagn 2013; 33: 815\u201322","DOI":"10.1002\/pd.4152"},{"key":"10.3238\/arztebl.m2025.0227_ref25","doi-asserted-by":"crossref","unstructured":"Kosian P, Hellmund A, Geipel A, et al.: Intrauterine transfusion in 103 fetuses with severe anemia caused by parvovirus infection. A multicenter retrospective study. Arch Gynecol Obstet 2023; 308: 117\u201325","DOI":"10.1007\/s00404-022-06712-z"},{"key":"10.3238\/arztebl.m2025.0227_ref26","doi-asserted-by":"crossref","unstructured":"Schneider MO, Faschingbauer F, Kagan KO, Gross U, Enders M, Kehl S: Toxoplasma-gondii-Infektion in der Schwangerschaft \u2013 Empfehlungen der Arbeitsgemeinschaft Geburtshilfe und Pr\u00e4natalmedizin (AGG \u2013 Sektion Maternale Erkrankungen). Geburtsh Frauenheilk 2023; 83: 1431\u201345","DOI":"10.1055\/a-2111-7394"},{"key":"10.3238\/arztebl.m2025.0227_ref27","doi-asserted-by":"crossref","unstructured":"Zeinali S, Khademvatan S, Jafari R, Vazifekhah S, Yousefi E, Behroozi-Lak T: Prevalence and risk factors of toxoplasma gondii infection among women with miscarriage and their aborted fetuses in the northwest of Iran. PLoS One 2023; 18: e0283493","DOI":"10.1371\/journal.pone.0283493"},{"key":"10.3238\/arztebl.m2025.0227_ref28","doi-asserted-by":"crossref","unstructured":"Hutson SL, Wheeler KM, McLone D, et al.: Patterns of hydrocephalus caused by congenital toxoplasma gondii infection associated with parasite genetics. Clin Infect Dis 2015; 61: 1831\u20134","DOI":"10.1093\/cid\/civ720"},{"key":"10.3238\/arztebl.m2025.0227_ref29","unstructured":"Mandelbrot L, Kieffer F, Sitta R, et al.: Prenatal therapy with pyrimethamine + sulfadiazine vs spiramycin to reduce placental transmission of toxoplasmosis: A multicenter, randomized trial. Am J Obstet Gynecol 2018; 219: 386.e1\u2013e9"},{"key":"10.3238\/arztebl.m2025.0227_ref30","doi-asserted-by":"crossref","unstructured":"McLeod R, Kieffer F, Sautter M, Hosten T, Pelloux H: Why prevent, diagnose and treat congenital toxoplasmosis? Mem Inst Oswaldo Cruz 2009; 104: 320\u201344","DOI":"10.1590\/S0074-02762009000200029"},{"key":"10.3238\/arztebl.m2025.0227_ref31","doi-asserted-by":"crossref","unstructured":"Wallon M, Kodjikian L, Binquet C, et al.: Long-termocular prognosis in 327 children with congenital toxoplasmosis. Pediatrics 2004; 113: 1567\u201372","DOI":"10.1542\/peds.113.6.1567"},{"key":"10.3238\/arztebl.m2025.0227_ref32","doi-asserted-by":"crossref","unstructured":"Strang AGGF, Ferrari RG, do Ros\u00e1rio DK, et al.: The congenital toxoplasmosis burden in Brazil: Systematic review and meta-analysis. Acta Trop 2020; 211: 105608","DOI":"10.1016\/j.actatropica.2020.105608"},{"key":"10.3238\/arztebl.m2025.0227_ref33","doi-asserted-by":"crossref","unstructured":"Wallon M, Peyron F, Cornu C, et al.: Congenital toxoplasma infection: Monthly prenatal screening decreases transmission rate and improves clinical outcome at age 3 years Clin. Infect Dis\u00a02013; 56: 1223\u201331","DOI":"10.1093\/cid\/cit032"},{"key":"10.3238\/arztebl.m2025.0227_ref34","doi-asserted-by":"crossref","unstructured":"Journ\u00e9 A, Garweg J, Ksiazek E, Peyron F, Binquet C, Wallon M: Long-term ocular outcomes in congenital toxoplasmosis treated perinatally. Pediatrics 2024; 153: e2023064114","DOI":"10.1542\/peds.2023-064114"},{"key":"10.3238\/arztebl.m2025.0227_ref35","doi-asserted-by":"crossref","unstructured":"Wallon M, Ksiazek E, Journe A, et al.: Congenital toxoplasmosis: Fewer clinical signs at 3 years of age over the last 15 years but stable risk of materno-fetal transmission. Clin Infect Dis 2025; 81: 648\u201350","DOI":"10.1093\/cid\/ciae634"},{"key":"10.3238\/arztebl.m2025.0227_ref36","unstructured":"Jansen K, Bremer V: Syphilis in Deutschland in den Jahren 2023 und 2024 \u2013 Neuer H\u00f6chststand von Infektionen mit Verlangsamung der Dynamik. Epid Bull 2025; 39: 3\u201324."},{"key":"10.3238\/arztebl.m2025.0227_ref37","unstructured":"Gjestland T: The Oslo study of untreated syphilis: An epidemiologic investigation of the natural course of the syphilitic infection based upon a re-study of the Boeck-Bruusgaard material. Acta Derm Venereol Suppl (Stockh)1955; 35 (Suppl 34): 3\u2013368."},{"key":"10.3238\/arztebl.m2025.0227_ref38","doi-asserted-by":"crossref","unstructured":"Tong H, Heuer A, Walker N: The impact of antibiotic treatment for syphilis, chlamydia, and gonorrhoea during pregnancy on birth outcomes: A systematic review and meta-analysis. J Glob Health 2023; 13: 04058","DOI":"10.7189\/jogh.13.04058"},{"key":"10.3238\/arztebl.m2025.0227_ref39","doi-asserted-by":"crossref","unstructured":"Walker GJ, Walker D, Molano Franco D, Grillo-Ardila CF: Antibiotic treatment for newborns with congenital syphilis. Cochrane Database Syst Rev 2019; 2: CD012071","DOI":"10.1002\/14651858.CD012071.pub2"},{"key":"10.3238\/arztebl.m2025.0227_ref40","unstructured":"https:\/\/derma.de\/fileadmin\/derma\/1_derma.de_WebRoot\/Aerzte\/Leitlinien\/059-002l_S2k_Diagnostik_Therapie_Syphilis_2014_07.pdf (last accessed on 12 February 2026)."}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2025.0227","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T11:07:07Z","timestamp":1779188827000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2025.0227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":40,"URL":"https:\/\/doi.org\/10.3238\/arztebl.m2025.0227","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]}}}